I'll tell you a secret. Addus HomeCare sends nurses into people's homes instead of hospitals, and the money moved in before Wall Street raised its forecast for them.
Fair value according to the model37.5% above the priceThe model puts fair value 37.5% above today's price. It weighs earnings, growth and risk.
Earnings estimatesupanalysts are raising their earnings estimates
How it ran against the rest42.1%Over the past period this stock did better than 42% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Company value on the exchange$2.3 bnAll shares together are worth about $2.3 billion. That makes it a smaller player, less known to the wider public.
Where's healthcare money heading right now? JD Health runs online pharmacies and doctor visits across China. Our model sees cash flowing into this stock, priced a third below what it's worth. That gap matters.
Fair value according to the model61.1% above the priceThe model puts fair value 61.1% above today's price. It weighs earnings, growth and risk.
Earnings estimatesstable
How it ran against the rest17.2%Over the past period this stock did better than 17% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Company value on the exchange$15.7 bnAll shares together are worth about $15.7 billion. That makes it a solid mid-sized company.
Sino Biopharmaceutical makes medicines sold across China, and you rarely see a stock climb twelve percent in one single day without a reason. Analysts just raised their profit expectations, and the money noticed first.
These are five out of 6,000+
The model runs through every stock each night. A free account shows you the full forecast on any stock, not just the five you see here.
Four out of five signals on Genpact agree: shares up twenty three percent this month, climbing faster than most stocks we track. Only risk disagrees, and that is worth watching, ticker G.
Fair value according to the model109.2% above the priceThe model puts fair value 109.2% above today's price. It weighs earnings, growth and risk.
Earnings estimatesstable
How it ran against the rest20.0%Over the past period this stock did better than 20% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Company value on the exchange$6.2 bnAll shares together are worth about $6.2 billion. That makes it a smaller player, less known to the wider public.
Five signals watch Qorvo, the company behind chips in phones and radios. Four say the same thing: earnings estimates keep rising, money moves in. One warns the price already ran up fast. Interesting split.
Fair value according to the model38.8% above the priceThe model puts fair value 38.8% above today's price. It weighs earnings, growth and risk.
Earnings estimatesstrong upanalysts are raising their earnings estimates sharply
How it ran against the rest39.0%Over the past period this stock did better than 39% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Company value on the exchange$8.4 bnAll shares together are worth about $8.4 billion. That makes it a smaller player, less known to the wider public.
Five more tomorrow
The model runs again every night. If you would rather not wait for tomorrow's selection, look up a stock yourself and see the full forecast.
Published on 22 August 2026. The presenters in these videos are AI-generated. This is not investment advice and not a recommendation; always do your own research.